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The primary structure of a human platelet proteoglycan (P.PG) core was established by a combination of amino acid 
sequence analysis and cDNA cloning. The deduced 13 1 amino acid long protein contains eight Ser-Gly repeats. The signi- 
ficance of homologies observed between P.PG and promyelocytic leukemia cell line proteoglycans is discussed. 
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1. INTRODUCTION 
A human platelet proteoglycan (P.PG) has been 
characterized as polydisperse molecules, the 
polydispersity being due to variations in the 
glycosylation and presumably sulphation levels. 
However the protein core appeared homogeneous 
for at least 90%; its N-terminal amino acid se- 
quence has been reported previously [l]. The pre- 
sent work deals with the elucidation of the 
complete primary structure of the P.PG estab- 
lished by two complementary techniques: peptide 
sequencing of various P.PG fragments and se- 
quencing of a cDNA coding for a proteoglycan in 
a human leukemic cell line (HEL). The latter 
presents megakaryocytic features [2-41: megaka- 
ryocytes have been shown to be implicated in 
platelet proteoglycan biosynthesis [5]. 
2. MATERIALS AND METHODS 
2.1. Sequence determination of P.PG peptides 
The human P.PG core was obtained as previously described 
[l]. Trypsin and chymotrypsin treatments were carried out in a 
50 mM Tris-HCl, pH 7.6, buffer at 37’C for 6 h at an en- 
zyme: substrate ratio of 1: 50. Cyanogen bromide (CNBr) treat- 
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ment was performed in 70% formic acid for 18 h at room 
temperature. Reverse-phase HPLC on an aquapore RP-300 col- 
umn (Brownlee) was performed in 0.1% trifluoroacetic acid 
(TFA) using a O-40% acetonitrile gradient (Gilson 
chromatograph). Sephadex G-50 gel filtration was performed 
on a 90 x 1 cm column in a 50 mM sodium bicarbonate, pH 8, 
buffer. Superose 6 gel filtration was performed on a HR lo/30 
column (Pharmacia) using a 50 mM sodium acetate, 4 M 
guanidinium hydrochloride (Gdn-HCl), pH 5.8, buffer. 
Automated Edman degradation was carried out on a 470 A se- 
quencer equipped with a 120 PTH analyser (Applied 
Biosystems). 
2.2. Screening of a HEL cell-derived cDNA library 
We took advantage of the homologies and differences bet- 
ween human P.PG [l] and rat yolk sac tumor proteoglycan core 
structures (PG19) [6] to synthesize a 26-mer oligonucleotide 
probe. 
The probe corresponding to residues 8-16 in P.PG: 
3’-AT&GT:ACCCAGGCGAC$TT&GGTCT-5’ OH 
was 5’-end labelled to screen a HEL cDNA hgt10 library [7]. 
Filter hybridization was carried out in 6 x SSC, 5 x Denhardt, 
0.5% SDS, 250pg/ml salmon sperm DNA for 18 h at 37’C. 
The filters were then washed five times at 42°C for 10 min in 
4 x SSC and subjected to autoradiography. The HEL derived 
clone was subcloned in Ml3 mp18 and mp19 and sequenced by 
the dideoxy-chain termination method [8]. 
3. RESULTS 
3.1. Protein core sequencing of the human P.PG 
Fig.1 presents the elution profile of the HPLC 
separation of the P.PG core tryptic peptides; the 
amino acid sequences of ten of them (Tl-TlO) 
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Fig.1. HPLC elution profile of a tryptic digest of the P.PG core. The elution was achieved with an acetonitrile linear gradient (O-40%) 
in 0.1% TFA, flow rate 1 ml/min. The sequences of the peptides (Tl-TlO) are indicated using the one letter amino acid abbreviation 
system. 
were determined. A CNBr peptide (CN) from the 
P.PG protein core was isolated after Sephadex 
G-SO gel filtration (not shown); its N-terminal 
amino acid sequence was determined up to residue 
29: the precise localization of these various 
fragments is presented below (fig.2). 
3.2. Cloning and sequencing of the HEL cell- 
derived cDNA: primary structure of the 
human P.PG 
Three positive clones were selected after screen- 
ing of lo5 plaques. One of them (P13) was P.PG 
specific. Its nucleotide and deduced amino acid se- 
quences are presented in fig.2. It consists of a 527 
nucleotides sequence coding for 94% of the P.PG 
protein core and a tail of 153 nucleotides in the 
3’-non coding region. Overlapping of the deduced 
protein sequence from the HEL cell-derived cDNA 
with the various P.PG peptides presented here and 
elsewhere [l] allowed us to establish the complete 
primary structure of the human P.PG core: 82% 
of the protein sequence was covered by protein se- 
quencing data. The P.PG protein core consists of 
a 131 amino acid long protein (Mr 14641) with 
eight Ser-Gly repeats. 
The only detected difference between the de- 
duced sequence from the cDNA clone and the 
various sequenced peptides resides at position 112 
in the P.PG core. A Ser residue was deduced at this 
position from the cDNA clone sequence (se- 
quenced in both directions) while an Asn residue 
was identified in peptides T7, T9 and CN. The 
presence of Ser in the cDNA clone might be due 
either to a cloning artifact or to polymorphism. 
Fig.2. Human P.PG core protein structure established from peptide sequencing experiments of the P.PG and the deduced amino acid 
sequence from the HEL cDNA clone nucleotide sequence. The tryptic peptides (Tl-TlO) characterized in the P.PG core are 
underlined, the double line indicates the CNBr fragment (CN), the dotted line represents the previously reported amino acid sequence 
(residues l-66) [l]. The boxed (deduced) Ser residue was identified as an Asn residue during protein sequencing experiments of the 
P.PG core; (a) the two glycosylation sites located in this work; (+) the XhoII restriction sites. Stop codon is indicated by three 
asterisks. The numbers on the right and left refer to the nucleotides and amino acids in the respective sequence. 
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GG TAC CAA TGG GTG CCC TGC AAT CCA 26 
Tyr Pm Thr Cln Arg Ala Arg Tyr Gln Trp Val Arg Cys Asn Pro 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
- T2 - -T6-- 
GAC ACT AAT TCT CCA AAC TGC CTT GAA GAA AAA CGA CCA ATG TTC 71 
Asp Set- Asn Ser Ala Asn Cys Leu Clu Glu Lys Cly Pro Met Phe 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
TII I I 
t 
GAA CTA CTT CCA GCT CAA TCC AAC AAG ATC CCC CGT CTG AGG ACT 116 
Glu Leu LPU Pro Cly Clu Ser Asn Lys Ile Pro Arg Leu Arg Thr 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
TlO I I 
L 
GAC CTT TTT CCA AAti ACC AGA ATC CAG CAC TTG AAT CGT ATC TTC 161 
Asp Leu Phe Pro Lys Thr Arg Ile Cln Asp Leu Asn Arg Ile Phe 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
- T8 - - T3 - 
T5 - 
CCA CTT TCT CAti GAC TAC TCT CGA TCA GGC TTC GGC TCC GGC TCC 206 
Pro Leu Ser Glu Asp Tyr Ser Gly Ser Cly Phe Gly Ser Gly Ser 
. . . . . . . . . . . . . . . . . . . . . . . * a 
v 
GCC TCT CGA TCA CGA TCT GGG ACT CGC TTC CTA ACL GAA ATG GAA 251 
Gly Ser Cly Ser Gly Ser Gly Ser Cly Phe Leu Thr Glu Met Clu 
c 
CAG CAT TAC CAA CTA GTA GAC GAA ACT CAT GCT TTC CAT GAC AAC 296 
Cln Asp Tyr Gin Leu Val Asp Glu Ser Asp Ala Phe His Asp Asn 
CN 
CTT AGG TCT CTT CAC AGG AGT CTG CCC TCA GAC AGC CAC CAC TTG 341 
Leu Arg Ser Leu Asp ArgISer( Leu Pro Ser Asp Ser Gln Asp Leu 
-"2-1~T9- 
I T7 
GGT CAA CAT GCT TTA GAA GAG GAT TTT ATG TTA TAA AAGACGATTTT 388 
Gly Gln His Cly Leu Glu Glu Asp Phe Met Leu *** 
I 
CCCACCTTCACACCAGGCAATGTAGTTACCATATTTTATGTACCATGGTTATATGATTA 447 
ATCTTGGCACAAAGAATTTTATAGAAATTTTTAAACATCTGAAAAAGAAGCTTAAGTTT 506 
TATCATCCTTTTTTTTCTCAT 527 
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3.3. Localization of glycosylated serine residues in has been shown in two different rat cell lines 
P.PG [6,101. 
After trypsin or chymotrypsin treatment of the The comparison between such human and rat 
native P.PG, two fractions, Tpg and Cpg respec- 
tively, were isolated by Superose 6 gel filtration; 
they contained the total hexuronate amount of the 
digested P.PG. The Tpg sequence (IFPLSEDYX- 
GXGF.. .) began at position 59 whereas Cpg 
(SEDYXGXGF.. .> began at position 63 in the 
P.PG (see fig.2). No amino acid (X) could be iden- 
tified at identical positions for both of them while 
serine residues were deduced from the cDNA se- 
quence. This result suggests that at least the two 
first serine residues in the Ser-Gly repeats are 
glycosylated in the P.PG. Tpg and Cpg behaved 
during Superose 6 gel filtration as untreated P.PG; 
this observation shows that P.PG is protease sen- 
sitive even in the vicinity of its glycosaminoglycan 
side chains, the latter being the main contributors 
of P.PG, Cpg and Tpg Kav values. This statement 
contrasts with the proposed protease resistance of 
secretory granules proteoglycans [9]. 
proteoglycans reveals a high level of strict 
homology in their N-terminal part (55%/66 amino 
acids of the human P.PG core). However the 
length of the Ser-Gly repeat structure and the C- 
terminal region are much more different (15 addi- 
tional Ser-Gly repeats in the rat proteoglycans and 
only 35% of strict homology following the Ser-Gly 
repeats). The extent of Ser-Gly repeats and the C- 
terminal region appear therefore to be species 
specific. 
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4. DISCUSSION 131 
Our data are consistent with the localization of 
a Ser-Gly repeat containing proteoglycan in human 
platelets. Such proteoglycan protein cores exist in 
various tumoral or transformed cell lines in rats 
[6, lo] as well as in humans ([ 1 l] and present data). 
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The cDNA sequence of a human promyelocytic 
leukemia cell line (HL-60) [ 1 l] appeared identical 
to that of our HEL clone. The HL-60 cell line is 
able to be induced to differentiate under certain in 
vitro conditions into cells that resemble neutro- 
phils, monocytes-macrophages, eosinophils and 
basophils [l 11, while the HEL cell line presents 
megakaryocytic features [2-41. The human P.PG 
described in this report might be the representative 
of a ubiquitous proteoglycan core in the he- 
mopoietic lineage. Similarly a structural identity 
between Ser-Gly repeat containing proteoglycans 
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